NMDAR expression in the cochlear nucleus and hearing damage in neonatal rats with hyperbilirubinemia.
- Author:
Ke-Fang LI
1
;
Kai-Xian DU
;
Yue-Xing JIANG
;
Xue-Lei DONG
;
Yan ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Animals, Newborn; Bilirubin; analysis; Cochlear Nucleus; chemistry; Evoked Potentials, Auditory, Brain Stem; Female; Hearing Disorders; etiology; Hyperbilirubinemia; complications; metabolism; Immunohistochemistry; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; analysis
- From: Chinese Journal of Contemporary Pediatrics 2010;12(3):201-204
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the role of N-methyl-D-aspartate-receptor (NMDAR) expression in the development of hearing damage in neonatal rats with hyperbilirubinemia.
METHODSSixty seven-day-old Sprague-Dawley rats were randomly injected with bilirubin of 100 microg/g (low-dose treatment group) or 200 microg/g (high-dose treatment group) or normal saline (control group). Auditory brainstem response (ABR) was examined. The concentrations of bilirubin in blood and brain were measured. NMDAR expression in the cochlear nucleus slices was examined by immunohistochemistry assay.
RESULTSABR reflecting threshold obviously increased, and I, II and III wave latency as well as I-II, II-III and I-III interval were more prolonged in the two bilirubin treatment groups when compared with the control group. The NMDAR expression in the cochlear nucleuse in the two bilirubin treatment groups was obviously lower than that in the control group. The NMDAR expression in the cochlear nucleuse was negatively correlated with the brain bilirubin content and the ABR reflecting threshold in the two bilirubin treatment groups.
CONCLUSIONSAn increased NMDAR activity may play an important role in hearing damage following hyperbilirubinemia.